Metabolic reprogramming in cancer: the bridge that connects intracellular stresses and cancer behaviors

Summary Extensive changes in cellular metabolisms have been observed in cancer. They are probably induced by the same intracellular stressor, persistent off-balance in intracellular pH across possibly all adult cancers. It is these altered metabolisms that gives rise to a variety of cancerous behaviors such as continuous cell division, metastasis and drug resistance.

• Publication year

  2020

• Venue

  National Science Review

• Publication date

  2020-04-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/nsr/nwaa082PMID 34692153PMCID 8288940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elucidation of Functional Roles of Sialic Acids in Cancer Migration

  2020cited by this paper
• Metabolic Reprogramming in Cancer is Induced to Increase Proton Production.

  2020cited by this paper
• Warburg Effects in Cancer and Normal Proliferating Cells: Two Tales of the Same Name

  2019cited by this paper
• Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides

  2019cited by this paper
• Fenton reactions drive nucleotide and ATP syntheses in cancer

  2018cited by this paper
• The chemistry, physiology and pathology of pH in cancer

  2014cited by this paper
• Iron and cancer: more ore to be mined

  2013cited by this paper
• Tumour heterogeneity and cancer cell plasticity

  2013cited by this paper
• On the origin of cancer metastasis.

  2013cited by this paper
• Sequestration and Scavenging of Iron in Infection

  2013cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Mechanical compression drives cancer cells toward invasive phenotype

  2011cited by this paper
• The catalytic pathway of cytochrome p450cam at atomic resolution.

  2000cited by this paper
• Metabolic basis for disorders of purine nucleotide degradation.

  1981cited by this paper
• Increased CTP synthetase activity in cancer cells

  1978cited by this paper

• Integrated Metabolomics and Lipidomics of Tissue and Serum Reveal Mechanistic Pathways and Lipid Signatures Distinguishing Meningioma Grades.

  2025cites this paper
• Factors Contributing to the High Malignancy Level of Cholangiocarcinoma and Its Epidemiology: Literature Review and Data

  2025influential citation
• Investigating the role of tumor cell heterogeneity and angiogenesis genes in the prognosis of multiple myeloma

  2025cites this paper
• On why cancer cells require a great amount of glucose

  2025cites this paper
• An afatinib-based theranostic fluorescent probe for cancer cells and its applications in monitoring pH changes during treatment

  2024cites this paper
• NIR-II imaging-guided precise photodynamic therapy for augmenting tumor-starvation therapy by glucose metabolism reprogramming interference.

  2024cites this paper
• A potent nano-strategy for dual energy deprivation to inhibit pancreatic cancer progression

  2024cites this paper
• The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages

  2023cites this paper
• Co-expression based cancer staging and application

  2020cites this paper